Overview
Location
United States, Maryland, Cambridge
Employees
11-50
Total raised
$31M
Founded date
2019
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 3, 2019 | NEA Joins $31M Series A for Tiburio Therapeutics | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan today announced the launch of Tiburio Therapeutics Inc. (Tiburio), a private biopharmaceutical company focused on developing treatments for rare neuroendocrine tumors and rare endocrine diseases. Tib... |
| Jan 3, 2019 | Tiburio Therapeutics Raises $31M Series A Financing | Tiburio Therapeutics, Inc., a Cambridge, MA-based biopharmaceutical company focused on developing treatments for rare neuroendocrine tumors and rare endocrine diseases, raised a $31M Series A financing. Backers included New Enterprise Assoc... |
| Jan 3, 2019 | Tiburio launches with $31M and clinical-stage drugs for rare endocrine diseases | Drug accelerator Cydan unveiled its third orphan drug company: Tiburio Therapeutics, which starts life with $31 million in series A funding and a pair of clinical-stage compounds licensed from Ipsen. The series A will support its lead asset... |
Reviews 0
FAQ about Tiburio
When was Tiburio founded?
Tiburio was founded in 2019.
How much funding has Tiburio raised?
Tiburio has raised $31M in total across 1 funding round.
What has the press written about Tiburio?
Parsers VC has collected 4 articles mentioning Tiburio, among them “NEA Joins $31M Series A for Tiburio Therapeutics” (Jan 3, 2019) and “Tiburio Therapeutics Raises $31M Series A Financing” (Jan 3, 2019).
Is Tiburio still active?
Tiburio is probably closed: its latest activity on Parsers VC dates from Jan 3, 2019.